Related Experiment Video

Updated: Feb 10, 2026

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

8.9K

Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different

Chung-Han Lee1, Roman Yelensky2, Karin Jooss2

  • 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Trends in Immunology
|May 13, 2018
PubMed

Insights

Neoantigens, arising from cancer cell mutations, are key regulators of antitumor immunity. Understanding and targeting these non-self-antigens offers promising new avenues for cancer vaccines and immunotherapies.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • Antitumor immunity is a complex process influenced by cancer cell mutations.
  • Neoantigens, resulting from somatic mutations, are critical factors in immune response against tumors.

Purpose of the Study:

  • To review the current understanding of neoantigens in cancer.
  • To discuss advancements in utilizing neoantigens for cancer immunotherapy.

Main Methods:

  • Literature review of recent research on neoantigens.
  • Analysis of the role of neoantigens in immune checkpoint blockade and cancer vaccines.

Main Results:

  • Neoantigens significantly impact the effectiveness of antitumor immunity.
  • Targeting neoantigens shows promise for novel diagnostic and therapeutic strategies.

Conclusions:

  • Neoantigens are crucial targets for enhancing cancer immunotherapy.
  • Further research into neoantigens will drive the development of next-generation cancer treatments.

More Related Videos

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models06:57

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Published on: April 7, 2018

11.4K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K